ADKINS SEALE CAPITAL MANAGEMENT LLC’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2K Hold
75
0.01% 186
2026
Q1
$13.8K Hold
75
0.01% 181
2025
Q4
$13.2K Buy
+75
New +$12.3K 0.01% 180

Other funds holding BIIB

ADKINS SEALE CAPITAL MANAGEMENT LLC's BIIB Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its Biogen (BIIB) position steady in Q2 2026 at 75 shares worth $16.2K. The position accounts for 0.01% of the portfolio, ranked #186.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 525 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 75 shares of Biogen worth $16.2K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #186 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 525 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.